Biomatrix Healthcare Private Limited Cephalexin Export Data — India (DGFT 2022–2026)

Name: Biomatrix Healthcare Private Limited Cephalexin Export Records India — #9 Exporter, 5 Shipments, $250.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Cephalexin

India Pharmaceutical Trade Intelligence

$349.5M223 Suppliers104 CountriesHS 30042012

ExportsIndia → UNITED STATES82.2%India → SRI LANKA5.2%

ImportsUNITED STATES → India$146.5K CROATIA → India$17.9K

#1 Supplier: ALKEM LABORATORIES #1 Buyer: ASCEND LABORATORIES,

Biomatrix Healthcare Private Limited — Cephalexin Exporter #9 | $250.0K Trade Value | TransData Nexus | TransData Nexus

Biomatrix Healthcare Private Limited — Cephalexin Exporter Profile

Indian Pharmaceutical Exporter · #9 for Cephalexin · $250.0K export value · DGFT Verified

Biomatrix Healthcare Private Limited is the #9 Indian exporter of Cephalexin with $250.0K in export value and 5 verified shipments. Biomatrix Healthcare Private Limited holds a 0.1% market share in Cephalexin exports across 2 countries. The company exports 15 pharmaceutical products worth $25.7M across 6 therapeutic categories.

Biomatrix Healthcare Private Limited — Cephalexin Export Profile: Buyers & Destinations

Biomatrix Healthcare Private Limited Cephalexin export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Cephalexin?

Country	Value	Shipments	Share
UNITED STATES	$67.0M	1,340	60.2%
SRI LANKA	$13.5M	270	12.1%
AUSTRALIA	$8.4M	195	7.5%
TANZANIA	$4.9M	107

Who Are the Top Buyers of Cephalexin from India?

Buyer	Country	Value	Orders
ASCEND LABORATORIES,LLC	UNITED STATES	$13.3M	266
ASCEND LABORATORIES LLC	UNITED STATES	$9.5M	190
BREATHEFREE LANKA PVT LTD	SRI LANKA	$6.8M	135
M/S. SUN PHARMA ANZ PTY LTD	AUSTRALIA	$3.8M	95
M S SUN PHARMA ANZ PTY LIMITED	AUSTRALIA	$1.6M	33
DYVENPRO DISTRIBUCION Y VENTA DE	ECUADOR	$1.1M	21
ASCEND LABORATORIES, LLC	UNITED STATES	$950.0K	19
ASCEND LABORATORIES, LLC.,	UNITED STATES	$350.0K	7
UNIQUE PHARMA,	CONGO DR	$150.0K	3
ASCEND LABORATORIES, LLC C/O UPS	UNITED STATES	$100.0K	2

India's Cephalexin is purchased by 516 buyers worldwide. The top buyer is ASCEND LABORATORIES,LLC (UNITED STATES), followed by ASCEND LABORATORIES LLC and BREATHEFREE LANKA PVT LTD.

How Does Biomatrix Healthcare Private Limited Compare to Nearest Cephalexin Exporters?

Exporters ranked immediately above and below #9 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
13	SANJIVANI PARANTERAL LIMITED	$700.0K	14	1	$50.0K
15	ALKEM LABORATORIES LTD	$650.0K	13	1	$50.0K
9	BIOMATRIX HEALTHCARE PRIVATE LIMITED ★	$250.0K	5	2	$50.0K

Biomatrix Healthcare Private Limited ranks #9 among 223 Indian Cephalexin exporters. Average shipment value of $50.0K compared to the market average of $488.4K. The closest competitors by value are SANJIVANI PARANTERAL LIMITED and ALKEM LABORATORIES LTD.

Which Indian Ports Ship Cephalexin Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	873	17.1%
SAHAR AIR	744	14.5%
DELHI AIR CARGO ACC (INDEL4)	538	10.5%
NHAVA SHEVA SEA (INNSA1)	398	7.8%
DELHI AIR	340	6.6%
JNPT/ NHAVA SHEVA SEA	275	5.4%
JNPT	220	4.3%
Bombay Air	163	3.2%

Geopolitical & Trade Policy Impact on Biomatrix Healthcare Private Limited's Cephalexin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Biomatrix. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight charges and extended transit times. These logistical hurdles can delay deliveries and escalate costs, particularly affecting time-sensitive pharmaceutical shipments. (pharmaceuticalcommerce.com)

Conversely, escalating US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, recent U.S. tariffs on imports from countries including India pose a significant challenge. These tariffs, reaching up to 50%, could impact nearly 55% of India's exports to the U.S., placing companies like Biomatrix at a competitive disadvantage due to increased costs. (apnews.com)

In the European Union, stringent regulatory frameworks such as the Falsified Medicines Directive necessitate compliance with rigorous safety and quality standards. For Biomatrix, obtaining European Market Authorization for products like Sitagliptin Tablets signifies a proactive approach to meeting these requirements, thereby facilitating smoother access to the EU market. (biomatrixhealthcare.com)

Biomatrix Healthcare Private Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened scrutiny regarding quality and compliance. India, housing over 600 US FDA-approved manufacturing sites, faces challenges in maintaining consistent quality standards. The US FDA's increased inspections, exceeding 200 in 2023 with plans for more in 2024, underscore the critical importance of compliance. (fact.net.in)

For Biomatrix, securing approvals from regulatory bodies such as the FDA Philippines and the Iraqi Ministry of Health reflects a commitment to upholding international quality standards. These achievements not only enhance the company's reputation but also serve as a competitive advantage in the global market. (biomatrixhealthcare.com)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Cephalexin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Biomatrix Healthcare Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 104+ countries, 516+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Cephalexin

Cephalexin

Biomatrix Healthcare Private Limited — Cephalexin Exporter Profile

Biomatrix Healthcare Private Limited — Cephalexin Export Profile: Buyers & Destinations

Where Does India Export Cephalexin?

Who Are the Top Buyers of Cephalexin from India?

What Is India's Total Cephalexin Export Value and How Much Does Biomatrix Healthcare Private Limited Contribute?

What Is the Average Shipment Value for Biomatrix Healthcare Private Limited's Cephalexin Exports?

How Does Biomatrix Healthcare Private Limited Compare to Other Indian Cephalexin Exporters?

Regulatory Requirements: Exporting Cephalexin to Key Markets

United States — FDA

Australia — TGA

How Does Biomatrix Healthcare Private Limited Compare to Nearest Cephalexin Exporters?

Which Indian Ports Ship Cephalexin Exports?

What Other Antibiotics Products Does Biomatrix Healthcare Private Limited Export?

Geopolitical & Trade Policy Impact on Biomatrix Healthcare Private Limited's Cephalexin Exports

Biomatrix Healthcare Private Limited — Regulatory Compliance & Quality Standards

About Biomatrix Healthcare Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Cephalexin Export Data from Biomatrix Healthcare Private Limited

Cephalexin Stats

Company Overview

Top Products by Biomatrix Healthcare Private Limited

Related Analysis

Need Detailed Export Data?

Data Source